Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-11-17

Clinical Trial Update: Assessing the Efficacy of Steroid Treatment of Achalasia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing steroid treatment for achalasia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Achalasia | Phase 4 | Status: WITHDRAWN